Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia

APMIS

Volumn 114, Issue 12, 2006, Pages 893-898

  Hu, Xiao Yong ^a   Xu, Yue Min ^a   Chen, Xiao Chun ^b   Ping, Hao ^b   Chen, Zhao Hui ^b   Zeng, Fu Qing ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

HtrA2; Apoptosis; Benign prostatic hyperplasia; Omi; Prostate cancer; Serine protease

Indexed keywords

MESSENGER RNA; SERINE PROTEINASE OMI;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; APOPTOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERINE ENDOPEPTIDASES; STATISTICS, NONPARAMETRIC;

EID: 33845706247     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2006.apm_271.x     Document Type: Article

References (22)

1. Foster CS, Cornford P, Forsyth L, Djamgoz MB, Ke Y. The cellular and molecular basis of prostate cancer. BJU Int 1999;83:171-94.
2. Watson RWG, Fitzpatrick JM. Target sites for manipulating apoptosis in prostate cancer. BJU Int 2000;85 (Suppl):S38-S44.
3. Gray CW, Ward RV, Karran E, Turconi S, Rowles A, Viglienghi D, et al. Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur J Biochem 2000;267:5699-710.
4. Faccio L, Fusco C, Viel A, Zervos AS. Tissue specific splicing of Omi stress-regulated endoprotease leads to an inactive protease with a modi-fied PDZ motif. Genomics 2000;68:343-7.
5. Li W, Srinivasula SM, Chai J, Li P, Wu JW, Zhang Z, Alnemri ES, Shi Y. Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi. Nat Struct Biol 2002;9:436-41.
6. Liu Z, Sun C, Olejniczak ET, Meadows RP, Betz SF, Oost T, et al. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature 2000;408:1004-8.
7. Wu G, Chai J, Suber TL, Wu JW, Du C, Wang X, et al. Structural basis of IAP recognition by Smac/DIABLO. Nature 2000;408:1008-12.
8. Hegde R, Srinivasula SM, Zhang Z, Wassell R, Mukattash R, Cilenti L, et al. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem 2002;277:432-8.
9. Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 2001;8:613-21.
10. Verhagen AM, Silke J, Ekert PG, Pakusch M, Kaufmann H, Connolly LM, et al. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 2002;277:445-54.
11. Suzuki Y, Takahashi-Niki K, Akagi T, Hashikawa T, Takahashi R. Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways. Cell Death Differ 2004;11:208-15.
12. Jin S, Kalkum M, Overholtzer M, Stoffel A, Chait BT, Levine AJ. CIAP1 and the serine protease HTRA2 are involved in a novel p53-dependent apoptosis pathway in mammals. Genes Dev 2003;17:359-67.
13. Savopoulos JW, Carter PS, Turconi S, Pettman GR, Karran EH, Gray CW, et al. Expression, purification, and functional analysis of the human serine protease HtrA2. Protein Expr Purif 2000;19:227-34.
14. Gaumont-Leclerc MF, Mukhopadhyay UK, Goumard S, Ferbeyre G. PEA-15 is inhibited by adenovirus E1A and plays a role in ERK nuclear export and Ras-induced senescence. J Biol Chem 2004;279:46802-9.
15. Trencia A, Fiory F, Maitan MA, Vito P, Barbagallo AP, Perfetti A, et al. Omi/HtrA2 promotes cell death by binding and degrading the antiapoptotic protein PED/PEA-15. J Biol Chem 2004;279:46566-72.
16. Martins LM, Iaccarino I, Tenev T, Gschmeissner S, Totty NF, Lemoine NR, et al. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J Biol Chem 2002;277:439-44.
17. Krojer T, Garrido-Franco M, Huber R, Ehrmann M, Clausen T. Crystal structure of DegP (HtrA) reveals a new protease-chaperone machine. Nature 2002;416:455-9.
18. Cilenti L, Kyriazis GA, Soundarapandian MM, Stratico V, Yerkes A, Park KM, et al. Omi/HtrA2 protease mediates cisplatin-induced cell death in renal cells. Am J Physiol Renal Physiol 2005;288:F371-F379.
19. Nie GY, Hampton A, Li Y, Findlay JK, Salamonsen LA. Identification and cloning of two isoforms of human HtrA3, characterisation of its genomic structure and comparison of its tissue distribution with HtrA1 and HtrA2. Biochem J 2003;371:39-48.
20. Faccio L, Fusco C, Chen A, Martinotti S, Bonventre JV, Zervos AS. Characterization of a novel human serine protease that has extensive homology to bacterial heat shock endoprotease HtrA and is regulated by kidney ischemia. J Biol Chem 2000;275:2581-8.
21. Lee SH, Jong Woo Lee, Kim HS, Kim SY, Park WS, Kim SH, et al. Immunohistochemical analysis of Omi/HtrA2 expression in stomach cancer. APMIS 2003;111:586-90.
22. McEleny KR, Watson RW, Coffey RN, O'Neill AJ, Fitzpatrick JM. Inhibitors of apoptosis proteins in prostate cancer cell lines. Prostate 2002;51:133-40.